EUVIMEDEUVIMED entdecken
Crossref

Minimal Invasive Treatments for Renal Cell Carcinoma

Selahattin Çalışkan, Mustafa Sungur

annals of urologic oncology · 2020

DOI: 10.32948/auo.2020.09.24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift annals of urologic oncology, 2020. Verfasst von Selahattin Çalışkan und 1 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC) is the most common malignancy of the kidney that accounts 85% of all renal tumors and 2-3% of all adult malignancies . The etiology of RCC associated with smoking , obesity, anti-hypertensive therapy, coffee and tea, Western diet (high fat and protein and low fruits and vegetables). However, the detection of small renal masses has been increased because of widespread use of sonography, computed tomography and magnetic resonance imaging techniques in recent years, but one-third of the patients with RCC still present with large, locally advanced or metastatic disease. Surgery is the main treatment for renal cell carcinoma and minimal invasive treatments such as laproscopy and robotic approaches is very popular in the world after the widespread use of technological instruments and technology.

Zitieren

APA

Çalışkan, S., & Sungur, M. (2020). Minimal Invasive Treatments for Renal Cell Carcinoma. annals of urologic oncology. https://doi.org/10.32948/auo.2020.09.24

Vancouver

Çalışkan S, Sungur M. Minimal Invasive Treatments for Renal Cell Carcinoma. annals of urologic oncology. 2020. doi:10.32948/auo.2020.09.24

BibTeX
@article{alkan2020,
  author = {Çalışkan, Selahattin and Sungur, Mustafa},
  title = {Minimal Invasive Treatments for Renal Cell Carcinoma},
  journal = {annals of urologic oncology},
  year = {2020},
  doi = {10.32948/auo.2020.09.24}
}
Kostenlos starten →